Open AccessFDA Approves Avastin in Combination with Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer
Publication year - 2006
Publication title -
cancer biology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.5.11.3543
Subject(s) - medicine , bevacizumab , lung cancer , carboplatin , oncology , chemotherapy , cancer , surgery , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom